Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos Escobar

Showing results (1-10 of 368) with videos related to

Pageof 37
Sort By:
Radiology Management|May 3, 2007
A/R systems reduce delayed and denied reimbursementsCarlos Escobar
Future Cardiology|June 1, 2018
Rivaroxaban: from ROCKET-AF trial to routine practice in SpainCarlos Escobar Cervantes
The Lancet. Diabetes & Endocrinology|July 11, 2024
SGLT2 inhibitors and GLP-1 receptor agonists: the definitive combination?Carlos Escobar Cervantes
Expert Review of Clinical Pharmacology|May 10, 2021
Fixed-dose combination of rosuvastatin and ezetimibe: treating hypercholesteremia according to cardiovascular riskVivencio Barrios, Carlos Escobar
The Canadian Journal of Cardiology|June 7, 2011
Hypertension, has treatment à la Carte arrived?Carlos Escobar, Vivencio Barrios
Future Cardiology|April 15, 2016
Clinical benefits of pitavastatin: focus on patients with diabetes or at risk of developing diabetesVivencio Barrios, Carlos Escobar
Journal of the American College of Cardiology|April 10, 2010
Rosuvastatin and cardiovascular continuum when time is importantVivencio Barrios, Carlos Escobar
Stroke|April 25, 2009
Importance of blood pressure control in hypertensive patients with coronary heart disease in clinical practice to reduce the risk of strokeVivencio Barrios, Carlos Escobar
American Heart Journal|April 21, 2009
Atrial fibrillation and atherothrombosis: the importance of anticoagulationCarlos Escobar, Vivencio Barrios
Southern Medical Journal|July 16, 2008
Antihypertensive agents: are all of them equal?Vivencio Barrios, Carlos Escobar
Pageof 37

Showing results (1-10 of 368) with videos related to

Sort By:
Pageof 37
Radiology Management|May 3, 2007
A/R systems reduce delayed and denied reimbursementsCarlos Escobar
Future Cardiology|June 1, 2018
Rivaroxaban: from ROCKET-AF trial to routine practice in SpainCarlos Escobar Cervantes
The Lancet. Diabetes & Endocrinology|July 11, 2024
SGLT2 inhibitors and GLP-1 receptor agonists: the definitive combination?Carlos Escobar Cervantes
Expert Review of Clinical Pharmacology|May 10, 2021
Fixed-dose combination of rosuvastatin and ezetimibe: treating hypercholesteremia according to cardiovascular riskVivencio Barrios, Carlos Escobar
The Canadian Journal of Cardiology|June 7, 2011
Hypertension, has treatment à la Carte arrived?Carlos Escobar, Vivencio Barrios
Future Cardiology|April 15, 2016
Clinical benefits of pitavastatin: focus on patients with diabetes or at risk of developing diabetesVivencio Barrios, Carlos Escobar
Journal of the American College of Cardiology|April 10, 2010
Rosuvastatin and cardiovascular continuum when time is importantVivencio Barrios, Carlos Escobar
Stroke|April 25, 2009
Importance of blood pressure control in hypertensive patients with coronary heart disease in clinical practice to reduce the risk of strokeVivencio Barrios, Carlos Escobar
American Heart Journal|April 21, 2009
Atrial fibrillation and atherothrombosis: the importance of anticoagulationCarlos Escobar, Vivencio Barrios
Southern Medical Journal|July 16, 2008
Antihypertensive agents: are all of them equal?Vivencio Barrios, Carlos Escobar
Pageof 37